HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jin Chen Selected Research

BmK AS polypeptide

9/2006The anti-nociceptive effect of BmK AS, a scorpion active polypeptide, and the possible mechanism on specifically modulating voltage-gated Na+ currents in primary afferent neurons.
1/2004Modulation of intracellular Na+ concentration by BmK AS, a scorpion toxin, in B104 cell line.
4/2003Modulation of BmK AS, a scorpion neurotoxic polypeptide, on voltage-gated Na+ channels in B104 neuronal cell line.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jin Chen Research Topics

Disease

157Neoplasms (Cancer)
06/2022 - 02/2002
39Neoplasm Metastasis (Metastasis)
05/2022 - 02/2002
33Inflammation (Inflammations)
04/2022 - 02/2002
22Breast Neoplasms (Breast Cancer)
04/2022 - 06/2002
22Infections
01/2022 - 01/2005
21Hepatocellular Carcinoma (Hepatoma)
01/2022 - 07/2012
17Carcinogenesis
12/2021 - 09/2003
15Lung Neoplasms (Lung Cancer)
01/2021 - 05/2005
13Heart Failure
01/2021 - 06/2005
11Hearing Loss (Hearing Impairment)
04/2022 - 01/2011
11Carcinoma (Carcinomatosis)
09/2021 - 06/2002
11Fibrosis (Cirrhosis)
05/2021 - 07/2007
9Osteosarcoma (Osteogenic Sarcoma)
12/2021 - 09/2008
9Sepsis (Septicemia)
03/2021 - 08/2009
8Pain (Aches)
03/2022 - 05/2008
7Melanoma (Melanoma, Malignant)
05/2022 - 01/2004
7Myocardial Infarction
01/2021 - 10/2010
6Stroke (Strokes)
10/2022 - 06/2016
6Hypoxia (Hypoxemia)
04/2022 - 06/2016
6Wounds and Injuries (Trauma)
12/2021 - 06/2003
6Necrosis
04/2021 - 02/2009
6Body Weight (Weight, Body)
03/2021 - 12/2007
6Ovarian Neoplasms (Ovarian Cancer)
01/2021 - 02/2006
6Non-alcoholic Fatty Liver Disease
01/2021 - 12/2014
6Hemorrhage
01/2021 - 09/2014
6Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2020 - 05/2014
6Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2019 - 01/2012
6Human Influenza (Influenza)
01/2019 - 12/2010
6Squamous Cell Carcinoma of Head and Neck
08/2018 - 05/2009
6Hyperlipoproteinemia Type I (Lipoprotein Lipase Deficiency, Familial)
12/2017 - 02/2015
5Atherosclerosis
01/2022 - 03/2012
5Hypertension (High Blood Pressure)
12/2021 - 01/2012
5Colorectal Neoplasms (Colorectal Cancer)
03/2021 - 05/2008
5Liver Neoplasms (Liver Cancer)
01/2021 - 02/2010
5Colonic Neoplasms (Colon Cancer)
01/2021 - 01/2004
5Obesity
01/2021 - 02/2015
5Type 2 Diabetes Mellitus (MODY)
04/2020 - 11/2013
5Glioma (Gliomas)
11/2019 - 01/2015
5Nasopharyngeal Carcinoma
02/2014 - 05/2002
5Vascular Remodeling
04/2006 - 11/2002
4Cognitive Dysfunction
10/2022 - 08/2020
4Ischemic Stroke
10/2022 - 06/2016
4Acne Vulgaris
08/2022 - 02/2016
4Adenocarcinoma of Lung
05/2022 - 02/2013

Drug/Important Bio-Agent (IBA)

52Proteins (Proteins, Gene)FDA Link
06/2022 - 06/2002
33Pharmaceutical PreparationsIBA
05/2022 - 01/2004
21Biomarkers (Surrogate Marker)IBA
01/2022 - 01/2005
20LigandsIBA
12/2017 - 02/2002
19LipidsIBA
01/2022 - 04/2002
15CytokinesIBA
01/2022 - 09/2003
15Phosphotransferases (Kinase)IBA
11/2021 - 09/2003
14Messenger RNA (mRNA)IBA
01/2021 - 03/2009
14EphA2 ReceptorIBA
11/2020 - 10/2002
13EphrinsIBA
11/2016 - 02/2002
12Therapeutic UsesIBA
06/2022 - 01/2012
12Eph Family Receptors (Eph Receptors)IBA
11/2016 - 02/2002
11Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2020 - 11/2002
10CateninsIBA
05/2022 - 01/2015
10Doxorubicin (Adriamycin)FDA LinkGeneric
03/2021 - 07/2005
10CurcuminIBA
01/2021 - 07/2014
10pradigastatIBA
10/2017 - 02/2015
9Long Noncoding RNAIBA
05/2022 - 12/2014
9EnzymesIBA
01/2022 - 02/2010
9MicroRNAs (MicroRNA)IBA
01/2021 - 03/2011
9Biological ProductsIBA
01/2020 - 03/2012
9VaccinesIBA
12/2018 - 01/2013
9EphA1 Receptor (Eph Receptor)IBA
11/2016 - 02/2002
8RNA (Ribonucleic Acid)IBA
01/2021 - 12/2014
8CholesterolIBA
06/2020 - 12/2007
8tyrosine receptor (receptor, tyrosine)IBA
01/2016 - 09/2003
7Triglycerides (Triacylglycerol)IBA
10/2022 - 11/2013
7AntigensIBA
01/2022 - 09/2005
7Interleukin-6 (Interleukin 6)IBA
10/2020 - 06/2009
7Insulin (Novolin)FDA Link
06/2020 - 10/2010
7AutoantibodiesIBA
06/2020 - 06/2005
7Ephrin-A1 (Ephrin A1)IBA
01/2020 - 10/2002
6DNA (Deoxyribonucleic Acid)IBA
05/2022 - 11/2013
6C-Reactive ProteinIBA
01/2021 - 12/2007
6Paclitaxel (Taxol)FDA LinkGeneric
09/2020 - 07/2005
6Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
04/2020 - 09/2003
6Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
12/2017 - 09/2003
6Tyrosine (L-Tyrosine)FDA Link
11/2016 - 01/2004
5Caspase 3 (Caspase-3)IBA
05/2022 - 09/2011
5Adenosine Triphosphatases (ATPase)IBA
01/2022 - 01/2011
5Glucose (Dextrose)FDA LinkGeneric
01/2022 - 10/2010
5GTP Phosphohydrolases (GTPases)IBA
11/2021 - 11/2005
5Small Interfering RNA (siRNA)IBA
01/2021 - 11/2006
5Oxygen (Dioxygen)IBA
01/2019 - 03/2012
5Taxoids (Taxanes)IBA
11/2012 - 07/2005
4LipopolysaccharidesIBA
12/2022 - 02/2016
4HDL CholesterolIBA
10/2022 - 11/2013
4Glutamic Acid (Glutamate)FDA Link
06/2022 - 05/2014
4Cadherins (E-Cadherin)IBA
05/2022 - 08/2015

Therapy/Procedure

51Therapeutics
06/2022 - 06/2003
18Drug Therapy (Chemotherapy)
05/2022 - 04/2002
7Transplantation
01/2022 - 12/2015
6Immunotherapy
05/2022 - 08/2010
6Radiotherapy
04/2022 - 03/2015
6Radiofrequency Ablation
01/2020 - 11/2012
5Lasers (Laser)
01/2022 - 02/2016